6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide

C88H68F5N13O4S — CID 162172659

IUPAC6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide
SMILESCn1nc(/C=C/c2cccc(F)c2)c2cc(N)c(F)cc21.O=C(Cc1cccs1)Nc1cc2c(/C=C/c3ccc4ccccc4c3)n[nH]c2cc1F.O=C(Nc1cc2c(/C=C/c3ccc4ccccc4c3)n[nH]c2cc1F)C1CC1.O=C1CC[C@@H](C(=O)Nc2cc3c(/C=C/c4ccc5ccccc5c4)n[nH]c3cc2F)N1
InChIInChI=1S/C25H18FN3OS.C24H19FN4O2.C23H18FN3O.C16H13F2N3/c26-21-15-23-20(14-24(21)27-25(30)13-19-6-3-11-31-19)22(28-29-23)10-8-16-7-9-17-4-1-2-5-18(17)12-16;25-18-13-21-17(12-22(18)27-24(31)20-9-10-23(30)26-20)19(28-29-21)8-6-14-5-7-15-3-1-2-4-16(15)11-14;24-19-13-21-18(12-22(19)25-23(28)16-8-9-16)20(26-27-21)10-6-14-5-7-15-3-1-2-4-17(15)11-14;1-21-16-9-13(18)14(19)8-12(16)15(20-21)6-5-10-3-2-4-11(17)7-10/h1-12,14-15H,13H2,(H,27,30)(H,28,29);1-8,11-13,20H,9-10H2,(H,26,30)(H,27,31)(H,28,29);1-7,10-13,16H,8-9H2,(H,25,28)(H,26,27);2-9H,19H2,1H3/b10-8+;8-6+;10-6+;6-5+/t;20-;;/m.0../s1
InChIKeyZNZLYKBUBOIIOR-IQCNRZCRSA-N
MW1498.66 g/mol
LogP19.49
Rot. Bonds15

About 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide

6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide (PubChem CID 162172659) has the molecular formula C88H68F5N13O4S and a molecular weight of 1498.66 g/mol. Its IUPAC name is 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide.

Molecular Properties

Compound Name6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide
PubChem CID162172659
Molecular FormulaC88H68F5N13O4S
Molecular Weight1498.66 g/mol
Exact Mass1497.52
IUPAC Name6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide
SMILESCn1nc(/C=C/c2cccc(F)c2)c2cc(N)c(F)cc21.O=C(Cc1cccs1)Nc1cc2c(/C=C/c3ccc4ccccc4c3)n[nH]c2cc1F.O=C(Nc1cc2c(/C=C/c3ccc4ccccc4c3)n[nH]c2cc1F)C1CC1.O=C1CC[C@@H](C(=O)Nc2cc3c(/C=C/c4ccc5ccccc5c4)n[nH]c3cc2F)N1
InChIInChI=1S/C25H18FN3OS.C24H19FN4O2.C23H18FN3O.C16H13F2N3/c26-21-15-23-20(14-24(21)27-25(30)13-19-6-3-11-31-19)22(28-29-23)10-8-16-7-9-17-4-1-2-5-18(17)12-16;25-18-13-21-17(12-22(18)27-24(31)20-9-10-23(30)26-20)19(28-29-21)8-6-14-5-7-15-3-1-2-4-16(15)11-14;24-19-13-21-18(12-22(19)25-23(28)16-8-9-16)20(26-27-21)10-6-14-5-7-15-3-1-2-4-17(15)11-14;1-21-16-9-13(18)14(19)8-12(16)15(20-21)6-5-10-3-2-4-11(17)7-10/h1-12,14-15H,13H2,(H,27,30)(H,28,29);1-8,11-13,20H,9-10H2,(H,26,30)(H,27,31)(H,28,29);1-7,10-13,16H,8-9H2,(H,25,28)(H,26,27);2-9H,19H2,1H3/b10-8+;8-6+;10-6+;6-5+/t;20-;;/m.0../s1
InChIKeyZNZLYKBUBOIIOR-IQCNRZCRSA-N
XLogP19.49
TPSA246.28 Ų
H-Bond Donors8
H-Bond Acceptors11
Rotatable Bonds15
Heavy Atoms111
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001498.66
LogP ≤ 519.49
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide?
The IUPAC name of 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide (CID 162172659) is 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide.
What is the SMILES notation for 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide?
The canonical SMILES for 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide is Cn1nc(/C=C/c2cccc(F)c2)c2cc(N)c(F)cc21.O=C(Cc1cccs1)Nc1cc2c(/C=C/c3ccc4ccccc4c3)n[nH]c2cc1F.O=C(Nc1cc2c(/C=C/c3ccc4ccccc4c3)n[nH]c2cc1F)C1CC1.O=C1CC[C@@H](C(=O)Nc2cc3c(/C=C/c4ccc5ccccc5c4)n[nH]c3cc2F)N1.
What is the InChIKey of 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide?
The InChIKey is ZNZLYKBUBOIIOR-IQCNRZCRSA-N. The full InChI is InChI=1S/C25H18FN3OS.C24H19FN4O2.C23H18FN3O.C16H13F2N3/c26-21-15-23-20(14-24(21)27-25(30)13-19-6-3-11-31-19)22(28-29-23)10-8-16-7-9-17-4-1-2-5-18(17)12-16;25-18-13-21-17(12-22(18)27-24(31)20-9-10-23(30)26-20)19(28-29-21)8-6-14-5-7-15-3-1-2-4-16(15)11-14;24-19-13-21-18(12-22(19)25-23(28)16-8-9-16)20(26-27-21)10-6-14-5-7-15-3-1-2-4-17(15)11-14;1-21-16-9-13(18)14(19)8-12(16)15(20-21)6-5-10-3-2-4-11(17)7-10/h1-12,14-15H,13H2,(H,27,30)(H,28,29);1-8,11-13,20H,9-10H2,(H,26,30)(H,27,31)(H,28,29);1-7,10-13,16H,8-9H2,(H,25,28)(H,26,27);2-9H,19H2,1H3/b10-8+;8-6+;10-6+;6-5+/t;20-;;/m.0../s1.
What are the key properties of 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide?
6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide has a molecular weight of 1498.66 g/mol, XLogP of 19.49, 15 rotatable bonds, 8 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 6-fluoro-3-[(E)-2-(3-fluorophenyl)ethenyl]-1-methylindazol-5-amine;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]cyclopropanecarboxamide;(2S)-N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-5-oxopyrrolidine-2-carboxamide;N-[6-fluoro-3-[(E)-2-naphthalen-2-ylethenyl]-1H-indazol-5-yl]-2-thiophen-2-ylacetamide is sourced from PubChem (CID 162172659), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).